Dale E. Shuster

Agricultural and Biological SciencesMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Pexidartinib Long-Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors”.

Pexidartinib Long-Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors

The Oncologist(2020)10.1002/onco.13629

N/A

1.9DataRank · unranked

61 citations

Hans Gelderblom, Michiel A. J. van de Sande, Silvia Stacchiotti, John H. Healey, William D. Tap +10 more

Long‐term outcomes of pexidartinib in tenosynovial giant cell tumors

Cancer(2020)10.1002/cncr.33312

N/A

0DataRank · unranked

70 citations

Andrew J. Wagner, William D. Tap, Emanuela Palmerini, Zev A. Wainberg, Jayesh Desai +11 more

Population Pharmacokinetic Analysis of Pexidartinib in Healthy Subjects and Patients With Tenosynovial Giant Cell Tumor or Other Solid Tumors

The Journal of Clinical Pharmacology(2020)10.1002/jcph.1753

N/A

0DataRank · unranked

12 citations

Andrew J. Wagner, Jia Kang, William Knebel, Hamim Zahir, Michiel A. J. van de Sande +6 more

Exposure–response analysis of efficacy and safety for pexidartinib in patients with tenosynovial giant cell tumor

CPT Pharmacometrics & Systems Pharmacology(2021)10.1002/psp4.12712

N/A

0DataRank · unranked

10 citations

Hamim Zahir, Jonathan French, Daniel Polhamus, Xiaoning Wang, Michiel A. J. van de Sande +8 more